Works by Holmes, Frankie A.


Results: 39
    1

    Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 1, p. 61, doi. 10.1007/s00280-006-0348-9
    By:
    • Beinart, Garth A.;
    • Gonzalez-Angulo, Ana M.;
    • Broglio, Kristine;
    • Frye, Debbie;
    • Walters, Ronald;
    • Holmes, Frankie Ann;
    • Gunale, Shivaji;
    • Booser, Daniel;
    • Rosenthal, Julian;
    • Dhingra, Kapil;
    • Young, James A.;
    • Hortobagyi, G. N.
    Publication type:
    Article
    2
    3

    Use of Taxol (Paclitaxel) in Breast Cancer.

    Published in:
    Oncology, 1994, v. 51, n. S1, p. 29, doi. 10.1159/000227413
    By:
    • Hortobagyi, Gabriel N.;
    • Holmes, Frankie A.;
    • Theriault, Richard L.;
    • Buzdar, Aman U.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.

    Published in:
    1993
    By:
    • Rubenstein, Edward B;
    • Rolston, Kenneth;
    • Escalante, Carmen;
    • Manzullo, Ellen;
    • Hughes, Pamela;
    • Fender, Andrew;
    • Elting, Linda;
    • Bodey, Gerald P.;
    • Holmes, Frankie;
    • Loewy, John;
    • Moreland, Betty;
    • Kennedy, Kathryn;
    • Benjamin, Robert S.;
    • Rubenstein, E B;
    • Rolston, K;
    • Benjamin, R S;
    • Loewy, J;
    • Escalante, C;
    • Manzullo, E;
    • Hughes, P
    Publication type:
    journal article
    11
    12

    Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 3, p. 264, doi. 10.1093/jnci/djq524
    By:
    • Iwamoto, Takayuki;
    • Bianchini, Giampaolo;
    • Booser, Daniel;
    • Yuan Qi;
    • Coutant, Charles;
    • Shiang, Christine Ya-Hui;
    • Santarpia, Libero;
    • Matsuoka, Junji;
    • Hortobagyi, Gabriel N.;
    • Symmans, William Fraser;
    • Holmes, Frankie A.;
    • O'Shaughnessy, Joyce;
    • Hellerstedt, Beth;
    • Pippen, John;
    • Andre, Fabrice;
    • Simon, Richard;
    • Pusztai, Lajos
    Publication type:
    Article
    13

    Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.

    Published in:
    2000
    By:
    • Hortobagyi, Gabriel N.;
    • Buzdar, Aman U.;
    • Theriault, Richard L.;
    • Valero, Vicente;
    • Frye, Debra;
    • Booser, Daniel J.;
    • Holmes, Frankie A.;
    • Giralt, Sergio;
    • Khouri, Issa;
    • Andersson, Borje;
    • Gajewski, James L.;
    • Rondon, Gabriela;
    • Smith, Terry L.;
    • Singletary, Sonja E.;
    • Ames, Frederick C.;
    • Sneige, Nour;
    • Strom, Eric A.;
    • McNeese, Marsha D.;
    • Deisseroth, Albert B.;
    • Champlin, Richard E.
    Publication type:
    journal article
    14

    Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer

    Published in:
    Cancer Medicine, 2018, v. 7, n. 6, p. 2288, doi. 10.1002/cam4.1472
    By:
    • Holmes, Frankie Ann;
    • Hellerstedt, Beth A.;
    • Pippen, Jr., John E.;
    • Vukelja, Svetislava J.;
    • Collea, Rufus p.;
    • Kocs, Darren M.;
    • Blum, Joanne L.;
    • Mcintyre, Kristi J.;
    • Barve, Minal A.;
    • Brooks, Barry D.;
    • Osborne, Cynthia R.;
    • Wang, Yunfei;
    • Asmar, Lina;
    • O'shaughnessy, Joyce
    Publication type:
    Article
    15

    PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.

    Published in:
    2019
    By:
    • Chia, Stephen K. L.;
    • Martin, Miguel;
    • Holmes, Frankie A.;
    • Ejlertsen, Bent;
    • Delaloge, Suzette;
    • Moy, Beverly;
    • Iwata, Hiroji;
    • von Minckwitz, Gunter;
    • Mansi, Janine;
    • Barrios, Carlos H.;
    • Gnant, Michael;
    • Tomašević, Zorica;
    • Denduluri, Neelima;
    • Šeparović, Robert;
    • Kim, Sung-Bae;
    • Jakobsen, Erik Hugger;
    • Harvey, Vernon;
    • Robert, Nicholas;
    • Smith II, John;
    • Harker, Graydon
    Publication type:
    journal article
    16
    17
    18
    19

    β-Lactam regimens for the febrile neutropenic patient.

    Published in:
    Cancer (0008543X), 1990, v. 65, n. 1, p. 9, doi. 10.1002/1097-0142(19900101)65:1<9::AID-CNCR2820650105>3.0.CO;2-C
    By:
    • Bodey, Gerald P.;
    • Fainstein, Victor;
    • Elting, Linda S.;
    • Anaissie, Elias;
    • Rolston, Kenneth;
    • Khardori, Nancy;
    • Kantarjian, Hagop;
    • Plager, Carl;
    • Murphy, William K.;
    • Holmes, Frankie;
    • Cabanillas, Fernando
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26

    Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

    Published in:
    2021
    By:
    • Chan, Arlene;
    • Moy, Beverly;
    • Mansi, Janine;
    • Ejlertsen, Bent;
    • Holmes, Frankie Ann;
    • Chia, Stephen;
    • Iwata, Hiroji;
    • Gnant, Michael;
    • Loibl, Sibylle;
    • Barrios, Carlos H.;
    • Somali, Isil;
    • Smichkoska, Snezhana;
    • Martinez, Noelia;
    • Garcia-Alonso, Mirta;
    • Link, John S.;
    • Mayer, Ingrid A.;
    • Cold, Søren;
    • Morales Murillo, Serafin;
    • Senecal, Francis;
    • Inoue, Kenichi
    Publication type:
    journal article
    27

    A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer.

    Published in:
    2020
    By:
    • Mahtani, Reshma;
    • Holmes, Frankie-Ann;
    • Badve, Sunil;
    • Caldera, Humberto;
    • Coleman, Robert;
    • Mamounas, Eleftherios;
    • Kalinsky, Kevin;
    • Kittaneh, Muaiad;
    • Lower, Elyse;
    • Pegram, Mark;
    • Press, Michael F;
    • Rugo, Hope S;
    • Schwartzberg, Lee;
    • Vogel, Charles;
    • Breast Cancer Therapy Expert Group (BCTEG)
    Publication type:
    journal article
    28
    29

    Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling.

    Published in:
    BMC Research Notes, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-0500-6-507
    By:
    • Holmes, Frankie Ann;
    • Espina, Virginia;
    • Liotta, Lance A.;
    • Nagarwala, Yasir M.;
    • Danso, Michael;
    • McIntyre, Kristi J.;
    • Osborne, Cynthia R. C.;
    • Anderson, Thomas;
    • Krekow, Lea;
    • Blum, Joanne L.;
    • Pippen, John;
    • Florance, Allison;
    • Mahoney, Janine;
    • O'Shaughnessy, Joyce A.
    Publication type:
    Article
    30
    31
    32

    Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.

    Published in:
    2018
    By:
    • Eustace, Alex J;
    • Conlon, Neil T;
    • McDermott, Martina S J;
    • Browne, Brigid C;
    • O'Leary, Patrick;
    • Holmes, Frankie A;
    • Espina, Virginia;
    • Liotta, Lance A;
    • O'Shaughnessy, Joyce;
    • Gallagher, Clair;
    • O'Driscoll, Lorraine;
    • Rani, Sweta;
    • Madden, Stephen F;
    • O'Brien, Neil A;
    • Ginther, Charles;
    • Slamon, Dennis;
    • Walsh, Naomi;
    • Gallagher, William M;
    • Zagozdzon, Radoslaw;
    • Watson, William R
    Publication type:
    journal article
    33

    A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer.

    Published in:
    JAMA: Journal of the American Medical Association, 2011, v. 305, n. 18, p. 1873, doi. 10.1001/jama.2011.593
    By:
    • Hatzis, Christos;
    • Pusztai, Lajos;
    • Valero, Vicente;
    • Booser, Daniel J.;
    • Esserman, Laura;
    • Lluch, Ana;
    • Vidaurre, Tatiana;
    • Holmes, Frankie;
    • Souchon, Eduardo;
    • Hongkun Wang;
    • Martin, Miguel;
    • Cotrina, José;
    • Gomez, Henry;
    • Hubbard, Rebekah;
    • Chacón, J. Ignacio;
    • Ferrer-Lozano, Jaime;
    • Dyer, Richard;
    • Buxton, Meredith;
    • Yun Gong;
    • Yun Wu
    Publication type:
    Article
    34

    Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG).

    Published in:
    Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 11, doi. 10.1007/s10549-018-4783-1
    By:
    • Abraham, Jame;
    • Coleman, Robert;
    • Elias, Anthony;
    • Holmes, Frankie Ann;
    • Kalinsky, Kevin;
    • Kittaneh, Muaiad;
    • Lower, Elyse;
    • Mahtani, Reshma;
    • Terry Mamounas, E.;
    • Pegram, Mark;
    • Vogel, Charles;
    • The Breast Cancer Therapy Expert Group (BCTEG)
    Publication type:
    Article
    35

    Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

    Published in:
    Breast Cancer Research & Treatment, 2012, v. 134, n. 1, p. 333, doi. 10.1007/s10549-012-2035-3
    By:
    • Santarpia, Libero;
    • Qi, Yuan;
    • Stemke-Hale, Katherine;
    • Wang, Bailiang;
    • Young, Elliana;
    • Booser, Daniel;
    • Holmes, Frankie;
    • O'Shaughnessy, Joyce;
    • Hellerstedt, Beth;
    • Pippen, John;
    • Vidaurre, Tatiana;
    • Gomez, Henry;
    • Valero, Vicente;
    • Hortobagyi, Gabriel;
    • Symmans, W.;
    • Bottai, Giulia;
    • Leo, Angelo;
    • Gonzalez-Angulo, Ana;
    • Pusztai, Lajos
    Publication type:
    Article
    36
    37
    38
    39